Human claudin-8 and -14 are receptors capable of conveying the cytotoxic effects of Clostridium perfringens enterotoxin

mBio

Volumn 4, Issue 1, 2013, Pages

  Shrestha, Archana ^a   McClane, Bruce A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLAUDIN; CLAUDIN 1; CLAUDIN 14; CLAUDIN 4; CLAUDIN 8; ENTEROTOXIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CLOSTRIDIUM PERFRINGENS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY TEST; FIBROBLAST; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SITE DIRECTED MUTAGENESIS;

EID: 84874640405     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00594-12     Document Type: Article

References (57)

1. McClane BA, Robertson SL, Li J. 2013. Clostridium perfringens, p 465-489. In Doyle MP, Buchanan RL (ed.), Food microbiology: fundamentals and frontiers, 4th ed. ASM Press, Washington, DC.
2. Sarker MR, Carman RJ, McClane BA. 1999. Inactivation of the gene (cpe) encoding Clostridium perfringens enterotoxin eliminates the ability of two cpe-positive C. perfringens type A human gastrointestinal disease isolates to affect rabbit ileal loops. Mol. Microbiol. 33:946-958.
3. Scallan E, Hoekstra RM, Angulo FJ, Tauxe RV, Widdowson M-A, Roy SL, Jones JL, Griffin PM. 2011. Foodborne illness acquired in the United States-major pathogens. Emerg. Infect. Dis. 17:7-15.
4. Carman RJ. 1997. Clostridium perfringens in spontaneous and antibiotic-associated diarrhoea of man and other animals. Rev. Med. Microbiol. 8(Suppl. 1):S43-S45.
5. McClane BA, Uzal FA, Miyakawa MF, Lyerly D, Wilkins TD. 2006. The enterotoxic Clostridia, p 688-752. In Dworkin M, Falkow S, Rosenberg E, Schleifer K-H, Stackebrandt E (ed.), The prokaryotes, 3rd ed. Springer Press, New York, NY.
6. Songer JG. 1996. Clostridial enteric diseases of domestic animals. Clin. Microbiol. Rev. 9:216-234.
7. Gao Z, McClane BA. 15 September 2012. Use of Clostridium perfringens enterotoxin and the enterotoxin receptor-binding domain (C-CPE) for cancer treatment: opportunities and challenges. J. Toxicol. http://dx.doi.org/10.1155/2012/981626.
8. Kojima T, Kyuno D, Sawada N. 2012. Targeting claudin-4 in human pancreatic cancer. Expert Opin. Ther. Targets 16:881-887.
9. Neesse A, Griesmann H, Gress TM, Michl P. 2012. Claudin-4 as therapeutic target in cancer. Arch. Biochem. Biophys. 524:64-70.
10. Deli MA. 2009. Potential use of tight junction modulators to reversibly open membranous barriers and improve drug delivery. Biochim. Biophys. Acta 1788:892-910.
11. Harada M, Kondoh M, Ebihara C, Takahashi A, Komiya E, Fujii M, Mizuguchi H, Tsunoda S, Horiguchi Y, Yagi K. 2007. Role of tyrosine residues in modulation of claudin-4 by the C-terminal fragment of Clostridium perfringens enterotoxin. Biochem. Pharmacol. 73:206-214.
12. Kondoh M, Takahashi A, Fujii M, Yagi K, Watanabe Y. 2006. A novel strategy for a drug delivery system using a claudin modulator. Biol. Pharm. Bull. 29:1783-1789.
13. Matsuhisa K, Kondoh M, Suzuki H, Yagi K. 2012. Comparison of mucosal absorption-enhancing activity between a claudin-3/-4 binder and a broadly specific claudin binder. Biochem. Biophys. Res. Commun. 423:229-233.
14. Rosenthal R, Heydt MS, Amasheh M, Stein C, Fromm M, Amasheh S. 2012. Analysis of absorption enhancers in epithelial cell models. Ann. N. Y. Acad. Sci. 1258:86-92.
15. Suzuki H, Kondoh M, Takahashi A, Yagi K. 2012. Proof of concept for claudin-targeted drug development. Ann. N. Y. Acad. Sci. 1258:65-70.
16. Takahashi A, Komiya E, Kakutani H, Yoshida T, Fujii M, Horiguchi Y, Mizuguchi H, Tsutsumi Y, Tsunoda S, Koizumi N, Isoda K, Yagi K, Watanabe Y, Kondoh M. 2008. Domain mapping of a claudin-4 modulator, the C-terminal region of C-terminal fragment of Clostridium perfringens enterotoxin, by site-directed mutagenesis. Biochem. Pharmacol. 75:1639-1648.
17. Czeczulin JR, Hanna PC, McClane BA. 1993. Cloning, nucleotide sequencing, and expression of the Clostridium perfringens enterotoxin gene in Escherichia coli. Infect. Immun. 61:3429-3439.
18. Briggs DC, Naylor CE, Smedley JG, III, Lukoyanova N, Robertson S, Moss DS, McClane BA, Basak AK. 2011. Structure of the food-poisoning Clostridium perfringens enterotoxin reveals similarity to the aerolysin-like pore-forming toxins. J. Mol. Biol. 413:138-149.
19. Kitadokoro K, Nishimura K, Kamitani S, Fukui-Miyazaki A, Toshima H, Abe H, Kamata Y, Sugita-Konishi Y, Yamamoto S, Karatani H, Horiguchi Y. 2011. Crystal structure of Clostridium perfringens enterotoxin displays features of beta-pore-forming toxins. J. Biol. Chem. 286: 19549-19555.
20. Wieckowski EU, Kokai-Kun JF, McClane BA. 1998. Characterization of membrane-associated Clostridium perfringens enterotoxin following pronase treatment. Infect. Immun. 66:5897-5905.
21. Wieckowski EU, Wnek AP, McClane BA. 1994. Evidence that an ~50kDa mammalian plasma membrane protein with receptor-like properties mediates the amphiphilicity of specifically-bound Clostridium perfringens enterotoxin. J. Biol. Chem. 269:10838-10848.
22. McClane BA, Wnek AP. 1990. Studies of Clostridium perfringens enterotoxin action at different temperatures demonstrate a correlation between complex formation and cytotoxicity. Infect. Immun. 58:3109-3115.
23. Robertson SL, Smedley JG, III, Singh U, Chakrabarti G, Van Itallie CM, Anderson JM, McClane BA. 2007. Compositional and stoichiometric analysis of Clostridium perfringens enterotoxin complexes in Caco-2 cells and claudin 4 fibroblast transfectants. Cell. Microbiol. 9:2734-2755.
24. Singh U, Van Itallie CM, Mitic LL, Anderson JM, McClane BA. 2000. Caco-2 cells treated with Clostridium perfringens enterotoxin form multiple large complex species, one of which contains the tight junction protein occludin. J. Biol. Chem. 275:18407-18417.
25. Chen J, Theoret JR, Shrestha A, Smedley JG, III, McClane BA. 2012. Cysteine scanning mutagenesis supports the importance of Clostridium perfringens enterotoxin amino acids 80-106 for membrane insertion and pore formation. Infect. Immun. 80:4078-4088.
26. Smedley JG, III, Uzal FA, McClane BA. 2007. Identification of a prepore large-complex stage in the mechanism of action of Clostridium perfringens enterotoxin. Infect. Immun. 75:2381-2390.
27. Matsuda M, Ozutsumi K, Iwahashi H, Sugimoto N. 1986. Primary action of Clostridium perfringens type A enterotoxin on HeLa and Vero cells in the absence of extracellular calcium: rapid and characteristic changes in membrane permeability. Biochem. Biophys. Res. Commun. 141:704-710.
28. McClane BA. 1994. Clostridium perfringens enterotoxin acts by producing small molecule permeability alterations in plasma membranes. Toxicology 87:43-67.
29. McClane BA, Hanna PC, Wnek AP. 1988. Clostridium perfringens type A enterotoxin. Microb. Pathog. 4:317-323.
30. McClane BA, McDonel JL. 1980. Characterization of membrane permeability alterations induced in Vero cells by Clostridium perfringens enterotoxin. Biochim. Biophys. Acta 600:974-985.
31. Chakrabarti G, McClane BA. 2005. The importance of calcium influx, calpain, and calmodulin for the activation of Caco-2 cell death pathways by Clostridium perfringens enterotoxin. Cell. Microbiol. 7:129-146.
32. Chakrabarti G, Zhou X, McClane BA. 2003. Death pathways activated in Caco-2 cells by Clostridium perfringens enterotoxin. Infect. Immun. 71: 4260-4270.
33. Singh U, Mitic LL, Wieckowski EU, Anderson JM, McClane BA. 2001. Comparative biochemical and immunochemical studies reveal differences in the effects of Clostridium perfringens enterotoxin on polarized Caco-2 cells versus Vero cells. J. Biol. Chem. 276:33402-33412.
34. Sherman S, Klein E, McClane BA. 1994. Clostridium perfringens type A enterotoxin induces concurrent development of tissue damage and fluid accumulation in the rabbit ileum. J. Diarrhoeal Dis. Res 12:200-207.
35. Smedley JG, III, Saputo J, Parker JC, Fernandez-Miyakawa ME, Robertson SL, McClane BA, Uzal FA. 2008. Noncytotoxic Clostridium perfringens enterotoxin (CPE) variants localize CPE intestinal binding and demonstrate a relationship between CPE-induced cytotoxicity and enterotoxicity. Infect. Immun. 76:3793-3800.
36. Anderson JM, Van Itallie CM. 2009. Physiology and function of the tight junction. Cold Spring Harb. Perspect. Biol. 1:a002584.
37. Farquhar MG, Palade GE. 1963. Junctional complexes in various epithelia. J. Cell Biol. 17:375-412.
38. Piontek J, Winkler L, Wolburg H, Müller SL, Zuleger N, Piehl C, Wiesner B, Krause G, Blasig IE. 2008. Formation of tight junction: determinants of homophilic interaction between classic claudins. FASEB J. 22:46-58.
39. Van Itallie CM, Anderson JM. 2006. Claudins and epithelial paracellular transport. Annu. Rev. Physiol. 68:403-429.
40. Krause G, Winkler L, Mueller SL, Haseloff RF, Piontek J, Blasig IE. 2008. Structure and function of claudins. Biochim. Biophys. Acta 1778: 631-645.
41. Anderson JM, Van Itallie CM. 1999. Tight junctions: closing in on the seal. Curr. Biol. 9:R922-R924.
42. Katahira J, Inoue N, Horiguchi Y, Matsuda M, Sugimoto N. 1997. Molecular cloning and functional characterization of the receptor for Clostridium perfringens enterotoxin. J. Cell Biol. 136:1239-1247.
43. Katahira J, Sugiyama H, Inoue N, Horiguchi Y, Matsuda M, Sugimoto N. 1997. Clostridium perfringens enterotoxin utilizes two structurally related membrane proteins as functional receptors in vivo. J. Biol. Chem. 272:26652-26658.
44. Robertson SL, Smedley JG, III, McClane BA. 2010. Identification of a claudin-4 residue important for mediating the host cell binding and action of Clostridium perfringens enterotoxin. Infect. Immun. 78:505-517.
45. Fujita K, Katahira J, Horiguchi Y, Sonoda N, Furuse M, Tsukita S. 2000. Clostridium perfringens enterotoxin binds to the second extracellular loop of claudin-3, a tight junction membrane protein. FEBS Lett. 476:258-261.
46. Sonoda N, Furuse M, Sasaki H, Yonemura S, Katahira J, Horiguchi Y, Tsukita S. 1999. Clostridium perfringens enterotoxin fragment removes specific claudins from tight junction strands: evidence for direct involvement of claudins in tight junction barrier. J. Cell Biol. 147:195-204.
47. Veshnyakova A, Piontek J, Protze J, Waziri N, Heise I, Krause G. 2012. Mechanism of Clostridium perfringens enterotoxin interaction with claudin-3/-4 protein suggests structural modifications of the toxin to target specific claudins. J. Biol. Chem. 287:1698-1708.
48. Veshnyakova A, Protze J, Rossa J, Blasig IE, Krause G, Piontek J. 2010. On the interaction of Clostridium perfringens enterotoxin with claudins. Toxins (Basel) 2:1336-1356.
49. Charoenphandhu N, Wongdee K, Tudpor K, Pandaranandaka J, Krishnamra N. 2007. Chronic metabolic acidosis upregulated claudin mRNA expression in the duodenal enterocytes of female rats. Life Sci. 19: 1729-1737.
50. Fujita H, Chiba H, Yokozaki H, Sakai N, Sugimoto K, Wada T, Kojima T, Yamashita T, Sawada N. 2006. Differential expression and subcellular localization of claudin-7,-8,-12,-13, and-15 along the mouse intestine. J. Histochem. Cytochem. 54:933-944.
51. Holmes JL, Van Itallie CM, Rasmussen JE, Anderson JM. 2006. Claudin profiling in the mouse during postnatal intestinal development and along the gastrointestinal tract reveals complex expression patterns. Gene Expr. Patterns 6:581-588.
52. Mitchell LA, Koval M. 2010. Specificity of interaction between Clostridium perfringens enterotoxin and claudin-family tight junction proteins. Toxins (Basel) 2:1595-1611.
53. Ling J, Liao H, Clark R, Wong MS, Lo DD. 2008. Structural constraints for the binding of short peptides to claudin-4 revealed by surface plasmon resonance. J. Biol. Chem. 283:30585-30595.
54. Kimura J, Abe H, Kamitani S, Toshima H, Fukui A, Miyake M, Kamata Y, Sugita-Konishi Y, Yamamoto S, Horiguchi Y. 2010. Clostridium perfringens enterotoxin interacts with claudins via electrostatic attraction. J. Biol. Chem. 285:401-408.
55. Winkler L, Gehring C, Wenzel A, Müller SL, Piehl C, Krause G, Blasig IE, Piontek J. 2009. Molecular determinants of the interaction between Clostridium perfringens enterotoxin fragments and claudin-3. J. Biol. Chem. 284:18863-18872.
56. McDonel JL, McClane BA. 1988. Production, purification and assay of Clostridium perfringens enterotoxin. Methods Enzymol. 165:94-103.
57. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275.